Status:
COMPLETED
Optimizing Local Anesthetic Concentration for Continuous Femoral Nerve Blocks
Lead Sponsor:
University of California, San Diego
Collaborating Sponsors:
The Cleveland Clinic
Conditions:
Total Knee Arthroplasty
Knee Pain
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This is a randomized, observer-masked, controlled study. Subjects will be patients undergoing bilateral total knee arthroplasty (TKA). One side (left or right) will be randomized to one of two treatme...
Detailed Description
The investigators propose to test the null hypothesis that differing concentrations of ropivacaine (0.1% vs. 0.4%) at an equal total dose has no impact on quadriceps muscle strength during a continuou...
Eligibility Criteria
Inclusion
- Primary, bilateral TKA
- Age 18 years or older
- Postoperative analgesic pain includes bilateral continuous femoral nerve blocks
Exclusion
- Chronic, high-dose opioid use
- History of opioid abuse
- Any neuro-muscular deficit of either femoral nerves and/or quadriceps muscles
- Pregnancy
- Incarceration
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00923598
Start Date
June 1 2009
End Date
April 1 2011
Last Update
December 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Cleveland Clinic, Main Campus
Cleveland, Ohio, United States, 44195